Compare Enveric Biosciences Inc (ENVB) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs ProShares UltraPro QQQ ETF — how do they compare? Enveric Biosciences Inc trades at $1.57 (market cap $6.20M), while ProShares UltraPro QQQ ETF trades at $74.72. The key difference: ProShares UltraPro QQQ ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | TQQQ | |
|---|---|---|
Market Cap | $6.20M | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $17.40 | $87.22 |
52-Week Low | $1.27 | $37.89 |
Enterprise Value | $1.30M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.56, up 1.3% on the day, with a bullish technical signal from moving averages and strong analyst support (75% buy ratings). The company reported four consecutive quarterly earnings beats in 2025, including a positive EPS of $0.85 in Q4, while recent news highlights progress in preclinical studies for its non-hallucinogenic psychiatric drug candidate EB-003.
Despite operational losses and negative ROE/ROA, ENVB's consistent earnings surprises and advancing pipeline present speculative growth potential. Key risks include cash burn, clinical trial outcomes, and regulatory hurdles, requiring careful risk assessment by investors.
TQQQ trades at $74.96, up 1.59% with a bullish technical signal supported by moving averages. The leveraged ETF shows strong momentum from AI-driven tech sector performance, though oscillators indicate neutral short-term sentiment. Recent institutional buying activity and positive media coverage highlight continued investor interest in Nasdaq-100 exposure through this 3x leveraged vehicle.
The outlook remains positive given robust tech earnings and AI infrastructure spending, but volatility decay and leverage risks require careful position sizing. TQQQ offers amplified Nasdaq-100 returns during bull markets but faces significant downside risk during market corrections, making it suitable for tactical rather than long-term holdings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
